F2 | Coagulation factor II (thrombin) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/54698/133719_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
SPP2 | Secreted phosphoprotein 2, 24kDa | Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
CFHR2 | Complement factor H-related 2 | Plasma proteins Predicted secreted proteins
| | ![](/images/38915/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/38915/103187_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
F9 | Coagulation factor IX | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
MBL2 | Mannose-binding lectin (protein C) 2, soluble | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/16782/ihc_cell_selected_60x60.jpg) | ![](/images/16782/37033_A_3_6_rna_selected_60x60.jpg) | Tissue enriched |
AHSG | Alpha-2-HS-glycoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/1524/4371_B_7_3_rna_selected_60x60.jpg) | Tissue enriched |
APOC4 | Apolipoprotein C-IV | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62671/144049_B_8_4_rna_selected_60x60.jpg) | Tissue enriched |
C9 | Complement component 9 | Disease related genes Plasma proteins Predicted secreted proteins
| ![](/images/29577/ihc_selected_60x60.jpg) | | ![](/images/2151/ihc_cell_selected_60x60.jpg) | ![](/images/2151/5802_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |
CFHR5 | Complement factor H-related 5 | Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images/40726/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/40726/103328_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
SERPINC1 | Serpin peptidase inhibitor, clade C (antithrombin), member 1 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/24007/52473_B_7_8_rna_selected_60x60.jpg) | Tissue enriched |
ACSM2A | Acyl-CoA synthetase medium-chain family member 2A | Enzymes Mitochondrial proteins Predicted membrane proteins
| ![](/images/57699/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/57699/133710_A_8_2_rna_selected_60x60.jpg) | Group enriched |
SLC10A1 | Solute carrier family 10 (sodium/bile acid cotransporter), member 1 | Predicted membrane proteins Transporters
| ![](/images/42727/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42727/95205_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
SLCO1B1 | Solute carrier organic anion transporter family, member 1B1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| ![](/images/50892/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/50892/113837_B_8_3_rna_selected_60x60.jpg) | Tissue enriched |
KNG1 | Kininogen 1 | Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/1616/ihc_cell_selected_60x60.jpg) | ![](/images/9809/27197_B_7_8_rna_selected_60x60.jpg) | Group enriched |
CYP2A6 | Cytochrome P450, family 2, subfamily A, polypeptide 6 | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46713/114685_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
APOA2 | Apolipoprotein A-II | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| ![](/images/25885/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25885/57292_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
CYP1A2 | Cytochrome P450, family 1, subfamily A, polypeptide 2 | Cancer-related genes Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/16531/ihc_cell_selected_60x60.jpg) | ![](/images/16531/36094_B_8_5_rna_selected_60x60.jpg) | Tissue enriched |
APOA5 | Apolipoprotein A-V | Disease related genes Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
SERPINA11 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 | Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
HAO2 | Hydroxyacid oxidase 2 (long chain) | Enzymes
| ![](/images/45773/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45773/113704_B_8_3_rna_selected_60x60.jpg) | Group enriched |
CFHR4 | Complement factor H-related 4 | Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
SERPINA10 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| ![](/images/48739/ihc_selected_60x60.jpg) | ![](/images/48739/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/48739/109287_B_8_5_rna_selected_60x60.jpg) | Tissue enriched |
SERPINA7 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 | Disease related genes Plasma proteins Predicted secreted proteins
| ![](/images/2803/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2803/7857_B_7_7_rna_selected_60x60.jpg) | Tissue enriched |
CYP4A22 | Cytochrome P450, family 4, subfamily A, polypeptide 22 | Enzymes Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
AL590714.1 | Uncharacterized protein | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
ITIH1 | Inter-alpha-trypsin inhibitor heavy chain 1 | Plasma proteins Predicted secreted proteins
| | ![](/images/42049/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/41639/91761_B_2_2_rna_selected_60x60.jpg) | Tissue enriched |
ACSM2B | Acyl-CoA synthetase medium-chain family member 2B | Enzymes Mitochondrial proteins Predicted membrane proteins
| ![](/images/57699/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/57699/133710_A_8_2_rna_selected_60x60.jpg) | Group enriched |
TAT | Tyrosine aminotransferase | Disease related genes Enzymes Plasma proteins Potential drug targets
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
HAO1 | Hydroxyacid oxidase (glycolate oxidase) 1 | Enzymes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49552/113323_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
UROC1 | Urocanate hydratase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| ![](/images/36254/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/36254/112993_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
ITIH2 | Inter-alpha-trypsin inhibitor heavy chain 2 | Plasma proteins Predicted secreted proteins
| ![](/images/59150/ihc_selected_60x60.jpg) | ![](/images/59150/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/59150/144114_B_8_4_rna_selected_60x60.jpg) | Tissue enriched |
SLC22A10 | Solute carrier family 22, member 10 | Predicted membrane proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
SERPIND1 | Serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/8639/21739_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |
SLC22A1 | Solute carrier family 22 (organic cation transporter), member 1 | Predicted membrane proteins Transporters
| ![](/images/29846/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29846/63688_B_9_7_rna_selected_60x60.jpg) | Tissue enriched |
CYP4A11 | Cytochrome P450, family 4, subfamily A, polypeptide 11 | Enzymes Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
SLC25A47 | Solute carrier family 25, member 47 | Mitochondrial proteins Predicted membrane proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
FGB | Fibrinogen beta chain | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/1901/6360_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
APOH | Apolipoprotein H (beta-2-glycoprotein I) | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3732/11044_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |
CFHR3 | Complement factor H-related 3 | Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
SAA4 | Serum amyloid A4, constitutive | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/60139/ihc_cell_selected_60x60.jpg) | ![](/images/60139/137738_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
FGA | Fibrinogen alpha chain | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51370/141892_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
ORM2 | Orosomucoid 2 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| ![](/images/46438/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46438/103658_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
BHMT | Betaine--homocysteine S-methyltransferase | Enzymes Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/38285/78554_B_8_2_rna_selected_60x60.jpg) | Group enriched |
CYP3A4 | Cytochrome P450, family 3, subfamily A, polypeptide 4 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33671/76711_B_9_7_rna_selected_60x60.jpg) | Group enriched |
GBP7 | Guanylate binding protein 7 | | ![](/images/51245/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51245/115138_B_8_4_rna_selected_60x60.jpg) | Tissue enriched |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/49793/141695_B_9_3_rna_selected_60x60.jpg) | Group enriched |
SLC17A3 | Solute carrier family 17 (organic anion transporter), member 3 | Predicted membrane proteins Transporters
| ![](/images/16569/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16569/38399_B_6_6_rna_selected_60x60.jpg) | Group enriched |
FGG | Fibrinogen gamma chain | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images/27529/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/27529/59691_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
GDF2 | Growth differentiation factor 2 | Disease related genes Plasma proteins Predicted secreted proteins
| ![](/images/23357/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/23357/142013_A_3_3_rna_selected_60x60.jpg) | Tissue enriched |
HPD | 4-hydroxyphenylpyruvate dioxygenase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | ![](/images/38322/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/38321/82548_B_1_5_rna_selected_60x60.jpg) | Group enriched |